SCHEMBL25820540

SCHEMBL25820540

O=C(Nc1cccc(Nc2ccccc2)c1)c1cc(Nc2ccnc3ccc(F)cc23)ccn1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNMT1 P26358 6/20 0.53
DNMT3A Q9Y6K1 5/20 0.53
CDK8 P49336 2/20 0.49
CCNC P24863 1/20 0.49
DNMT3L Q9UJW3 3/20 0.47
EGFR P00533 2/20 0.46
TGFBR1 P36897 1/20 0.45
KDR P35968 2/20 0.45
KCNK3 O14649 1/20 0.45
KCNK9 Q9NPC2 1/20 0.45
EHMT1 Q9H9B1 1/20 0.44
GAK O14976 1/20 0.44
USP2 O75604 2/20 0.44
MAPT P10636 2/20 0.44
KMT2A Q03164 2/20 0.44
CLK2 P49760 1/20 0.44
ACVR1 Q04771 1/20 0.44
CLK4 Q9HAZ1 1/20 0.44
DYRK1B Q9Y463 1/20 0.44
FADS1 O60427 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30290890 0.95 DNMT1 (0.52) DNMT1DNMT3ACDK8CCNCDNMT3L
SCHEMBL24010174 0.95 DNMT1 (0.52) DNMT1DNMT3ACDK8CCNCDNMT3L
SCHEMBL25820533 0.89 DNMT1 (0.68) DNMT1DNMT3ACDK8CCNCDNMT3L
SCHEMBL30290755 0.89 DNMT1 (0.68) DNMT1DNMT3ACDK8CCNCDNMT3L
SCHEMBL24011122 0.89 DNMT1 (0.68) DNMT1DNMT3ACDK8CCNCDNMT3L
SCHEMBL24003883 0.89 DNMT1 (0.62) DNMT1DNMT3ACDK8CCNCDNMT3L
SCHEMBL24006221 0.88 KMT2A (0.57) DNMT1DNMT3ACDK8CCNCDNMT3L
SCHEMBL24003819 0.87 DNMT1 (0.53) DNMT1DNMT3ACDK8CCNCDNMT3L
SCHEMBL25820544 0.87 CDK8 (0.48) DNMT1DNMT3ACDK8CCNCDNMT3L
SCHEMBL25820660 0.86 DNMT1 (0.59) DNMT1DNMT3ACDK8CCNCDNMT3L

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219927-A1 AKT3 MODULATORS Georgiamune Inc. 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219927-A1 AKT3 MODULATORS AKT3, AKT2, PIK3CA DNMT1 4335/4885DNMT3A 4603/4885CDK8 385/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.